REVOLADE™ 50mg (Eltrombopag Olamine)

Revolade® Tablets 50 mg (Eltrombopag) by Novartis are an oral medication used to treat low platelet counts (thrombocytopenia) in patients with chronic immune thrombocytopenia (ITP), chronic hepatitis C-associated thrombocytopenia, or severe aplastic anemia. Eltrombopag works by stimulating the production of platelets in the bone marrow, helping to reduce the risk of bleeding and improve overall blood clotting. Revolade® should be used under the supervision of a qualified healthcare professional, with regular monitoring of platelet counts and liver function to ensure safe and effective therapy.